NCT07027371

Brief Summary

The goal of this trial is to evaluate compliance to booster vaccines and chemoprophylaxis in children who underwent a splenectomy and to assess the knowledge regarding this aspect before and after giving education.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2023

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

June 4, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
Last Updated

June 18, 2025

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

June 4, 2025

Last Update Submit

June 16, 2025

Conditions

Keywords

Overwhelming post splenectomy infectionssplenectomychemoprophylaxisvaccinationencapsulated organisms

Outcome Measures

Primary Outcomes (1)

  • Candidates' knowledge about the different aspects of post splenectomy hazards and methods of care

    A questionnaire designed by the hematology team inquiring about different aspects of post splenectomy hazards and methods of care was handed to candidates. Each correct answer was given a score of 1. A score was summed up and a total score (as a percentage of correct answers) was given.

    At baseline and immediately after intervention

Secondary Outcomes (2)

  • To detect the rate of vaccination (defined as the percentage of people who have received vaccines) to pneumococcal, meningococcal and hemophilus influenza vaccine among the studied population (splenectomized patients).

    At time of enrollment in the study

  • To detect the percentage of patients who received post splenectomy chemoprophylaxis among the studied population.

    At time of enrollment in the study

Study Arms (1)

Interventional group

EXPERIMENTAL

Splenectomized patients above 15 years and caregivers of patients below 15 years received a questionnaire that included questions enquiring about age, gender, education level, disease type, duration of illness, age at splenectomy, duration since splenectomy, reception of preoperative vaccines, compliance to post splenectomy booster doses and penicillin prophylaxis, and the reasons for non-compliance if any, and their perception regarding red flags of Overwhelming Post Splenectomy Infection "OPSI". Based on the gaps of care identified in the essential questionnaire, educational material about perisplenectomy care was obtained. A knowledge test and a printed brochure were designed based on the knowledge script. Candidates who agreed to complete the study were asked to fill in individually the pre-education knowledge test. The brochures were then handed to each patient or caregiver. Participants were encouraged to read the brochure. Then they completed the post-education knowledge test

Behavioral: Health education

Interventions

Health education was given in the form of a printed colored brochure designed in easy-to-understand Arabic language. Participants were encouraged to read the brochure thoroughly and as many times as needed and to ask questions to the researchers if they had any.

Interventional group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients above 15 years who had undergone splenectomy
  • Caregivers of patients aged below 15 years who had undergone splenectomy

You may not qualify if:

  • Illiterate candidates
  • Candidates who refuse to take part in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pediatrics, Faculty of Medicine, Cairo University

Cairo, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Pediatrics

Study Record Dates

First Submitted

June 4, 2025

First Posted

June 18, 2025

Study Start

December 15, 2021

Primary Completion

December 18, 2022

Study Completion

July 7, 2023

Last Updated

June 18, 2025

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

The datasets used and/or analysed during the current study are available from the investigator on reasonable request

Locations